OCT 30, 2014 12:00 PM PDT

The metabolic microenvironment in tumors and its impact on T-cell mediated immunity

Speakers
  • Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria
    Biography
      Dr. Julian J. Lum graduated with a PhD in Immunology from the University of Ottawa. He spent five years training at the University of Pennsylvania in the field of cancer biology with special emphasis on tumor metabolism. There he studied how cells adapt to nutrient stress and the role of autophagy in promoting cancer cell survival. In 2008, Dr. Lum returned to Canada and joined the Deeley Research Centre at the BC Cancer Agency, as a Scientist where his current research interest is in autophagy and metabolism of clear cell ovarian adenocarcinoma. He hopes the information gained from this work will enable a better understanding of how the tumor microenvironment influences the immune response to cancer. Dr. Lum is an Assistant Professor with the Department of Biochemistry and Microbiology, University of Victoria. He is also the recipient of a CIHR New Investigator Award. His work is funded by the BC Cancer Foundation, CIHR and Genome BC.  

    Abstract:

    It has become widely accepted that the presence of intraepithelial CD8+ T cell correlate with improved patient survival. In contrast, tumors largely devoid of immune infiltrations or infiltrates skew towards a suppressive phenotype are associated with poor outcomes. In this talk, I will discuss the metabolic constraints imposed by the tumor microenvironment and how this may impact T cell responses against tumors. Specific emphasis will be placed on the condition of hypoxia, its role in the regulation of T cell differentiation, effector function and survival. Initially using ovarian cancer as a disease site, our recently work shows that the tumor microenvironment plays a significant role in dictating the presence and function of T cells. We used a multi-parameter immunohistochemical staining system to co-identify markers of the tumor vasculature and the relative expression of T cells within these regions. We find few T cells co-localizing to areas of hypoxia, whereas most T cells are present in areas of high vascularity. Moreover, there was an association towards improved survival when T cells were detected in vascular environments of the tumor. These observations are consistent with our in vitro work showing that T cells undergoing hypoxia-induced autophagy have impaired cytolytic activity. Overall, this indicates that a T cell response requires overcoming the barriers of the metabolic tumor environment and this may have important implications for T cell-based therapies for the treatment of cancer.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    Loading Comments...
    Show Resources